![]() VIARTIS
|
||||||||||||
PARKINSON'S DISEASE NEWS |
||||||||||||
|
Parkinson's Disease News covers all significant new research, reports, books, and resources concerning Parkinson's Disease. Articles are chosen on the basis of their medical significance or potential interest. Our overwhelming priority is the facts, regardless of whether they contradict prevailing views or vested interests. Analysis and further information are provided either to explain the background or implications, or to balance misleading claims. If you notice errors or inadequacies, or dispute what is written, or want to propose articles, please e-mail [email protected].
21st August 2016 - New research NASAL GEL MAGNIFIES PARKINSON'S DISEASE DRUG EFFECTS
A nasal gel has been developed that can greatly increase the bioavailability of ropinirole. Ropinirole (Requip), which is a dopamine agonist for the treatment of Parkinson's Disease, normally has low bioavailability when it is taken orally. For more information go to : Ropinirole
The bioavailability of ropinirole in the brain was increased by five times when administered nasally using the gel when compared to intravenous administration. Thermoreversible nasal gel was consequently found to be a promising means of increased drug delivery for Parkinson's Disease. Reference : Drug Development and Industrial Pharmacy [2016] Aug 17 : 1-34 [Epub ahead of print] (M.Rao, D.K.Agrawal, C.Shirsath Complete abstract For more news go to Parkinson's Disease News
|
|
||||||||||
![]() |
||||||||||||
©2006-2016 Viartis | ||||||||||||
2016-08-21 17:11:17 | ||||||||||||
[email protected] |